Alex Nyström (Frieburg) presented his work on the discovery of potential therapeutic targets in epidermolysis bullosa, which is caused by mutations in COL7A1. Paul Potter (Oxford) presented his latest work on Lama5 point mutations in a novel model of nephrotic syndrome and Keerthi Harikrishnan (South Carolina) presented her work on Fibulin‐1 and its role during aortic and pulmonary valve morphogenesis. This evidence concerns the gene LAMA5 and nephrotic syndrome.